Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Koza

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|May 22, 2001
Allogeneic BMT in patients above 45 years of age: a single center experienceD Lysák, V Koza, P Jindra, et al.
Neoplasma|June 25, 2013
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert)P Jindra, J Muzik, K Indrak, et al.
Vnitrni Lekarstvi|February 16, 2007
[Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]E Faber, V Koza, A Vítek, et al.
Neoplasma|August 11, 2007
Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation RegistryE Faber, V Koza, A Vitek, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Neoplasma|April 29, 2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CTT Papajik, M Myslivecek, M Skopalova, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Neoplasma|September 18, 2010
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech RepublicT Szotkowski, J Muzik, J Voglova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 8, 2011
[Treatment of patients with relapsed/refractory Hodgkin lymphoma]H Mociková, R Pytlík, L Raida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|May 22, 2001
Allogeneic BMT in patients above 45 years of age: a single center experienceD Lysák, V Koza, P Jindra, et al.
Neoplasma|June 25, 2013
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert)P Jindra, J Muzik, K Indrak, et al.
Vnitrni Lekarstvi|February 16, 2007
[Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]E Faber, V Koza, A Vítek, et al.
Neoplasma|August 11, 2007
Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation RegistryE Faber, V Koza, A Vitek, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Neoplasma|April 29, 2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CTT Papajik, M Myslivecek, M Skopalova, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Neoplasma|September 18, 2010
Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech RepublicT Szotkowski, J Muzik, J Voglova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 8, 2011
[Treatment of patients with relapsed/refractory Hodgkin lymphoma]H Mociková, R Pytlík, L Raida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Pageof 6